People · Operator
Named in public records as an officer, director or promoter · active 2016–2025 · Biotechnology, Other Technology, Other Health Care
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Oncocyte Corp | — | Biotechnology | Series B | $83.0M | $119.1M | 2016 |
| ComHear, Inc. | — | Other Technology | Series B | $32.4M | $303.4M | 2017 |
| Independa, Inc. | — | Other Health Care | Series A | $13.6M | $28.3M | 2019 |
Andrew Arno at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Andrew Arno on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Jon Sundt | 2 | 2 |
| Alfred D Kingsley | 1 | 6 |
| Michael D West | 1 | 6 |
| Magda Marquet | 1 | 6 |
| Mitch Levine | 1 | 4 |
| Mark Hill | 1 | 4 |
| Joseph Wagner | 1 | 3 |
| Robert W Peabody | 1 | 3 |
| Brad Buss | 1 | 3 |
| Gene Barduson | 1 | 2 |
| Andrew Sassine | 1 | 2 |
| Jennifer Levin Carter | 1 | 2 |
| Jaye Connolly | 1 | 2 |
| Andrew W. Arno | 1 | 2 |
| Scott Braun | 1 | 2 |
| John Carrington | 1 | 2 |
| Douglas T. Ross | 1 | 2 |
| Adam Braun | 1 | 2 |
| Nick Dangerfield | 1 | 2 |
| James Liu | 1 | 2 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.